What is GRNQ's health score?

Greenpro Capital Corp. (GRNQ) has a TradeApes health score of 33 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is GRNQ's estimated fair value?

Based on our 5-year discounted cash flow model, Greenpro Capital Corp.'s estimated fair value is $0.69 per share, representing a -57.1% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is GRNQ undervalued or overvalued?

Our model currently rates GRNQ as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for GRNQ... Refresh in a moment for the full analysis.

Greenpro Capital Corp. (GRNQ)

Industrials Overvalued low weak

$1.6

Updated: 2026-06-05

TradeApes Score

Financial Strength

30 Weak

Operating Trend

18 Stressed

Relative Value

40 Weak

Capital Allocation

30 Weak

Risk

65 Healthy

Est. Fair Value $0.69

DCF Upside -57.1%

Sector Rank #405 of 3814

Key Findings

+ Low leverage — net debt/EBITDA below 1×

Unlock Full Report →

− Sharp revenue decline — sales down more than 15% year over year

Unlock Full Report →

Create an account for unlimited access

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.